Tomoaki Ishigami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tomoaki Ishigami has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Hisao Ochiai
From Yokohama City University, Internal Medicine II, Yokohama City, Japan
1 shared publicationIzumi Kobayashi
From Yokohama City University, Internal Medicine II, Yokohama City, Japan
1 shared publicationKiyoshi Hibi
From Yokohama City University, Internal Medicine II, Yokohama City, Japan
1 shared publicationKouichi Tamura
From Yokohama City University, Internal Medicine II, Yokohama City, Japan
1 shared publicationMinoru Kihara
From Yokohama City University, Internal Medicine II, Yokohama City, Japan
1 shared publicationSatoshi Umemura
From Yokohama City University, Internal Medicine II, Yokohama City, Japan
1 shared publication
Latest Publications
- 1 September 1999
- Published by Wolters Kluwer Health in Hypertension
- Vol. 34 (3) , 430-434
Angiotensinogen Gene Polymorphism Near Transcription Start Site and Blood Pressure
—Molecular variants of the angiotensinogen gene, a key component of the renin-angiotensin system, are considered genetic risk factors for primary hypertension. A relation between the angiotensinogen gene locus and hypertension has been found in whites, Japanese, and African Caribbeans but not in Chinese. The lack of a consistent association between M235T polymorphism at exon 2 and hypertension has suggested that another site in linkage disequilibrium with M235T is the causal mutation. We studied the relations among plasma angiotensinogen concentrations, blood pressure, related clinical variables, and mutations of the 5′ upstream core promoter region of the human angiotensinogen gene in 274 subjects recruited from our outpatient clinic. We confirmed that plasma angiotensinogen concentration was significantly correlated with A−20C mutation and percent body fat and found that systolic and diastolic blood pressures were significantly correlated with G−6A and T+68C mutations. These results suggest that mutations near the transcription start site may be associated with increased blood pressure.
- 1 September 1999
- Published by Wolters Kluwer Health in Hypertension
- Vol. 34 (3) , 430-434
Angiotensinogen Gene Polymorphism Near Transcription Start Site and Blood Pressure
—Molecular variants of the angiotensinogen gene, a key component of the renin-angiotensin system, are considered genetic risk factors for primary hypertension. A relation between the angiotensinogen gene locus and hypertension has been found in whites, Japanese, and African Caribbeans but not in Chinese. The lack of a consistent association between M235T polymorphism at exon 2 and hypertension has suggested that another site in linkage disequilibrium with M235T is the causal mutation. We studied the relations among plasma angiotensinogen concentrations, blood pressure, related clinical variables, and mutations of the 5′ upstream core promoter region of the human angiotensinogen gene in 274 subjects recruited from our outpatient clinic. We confirmed that plasma angiotensinogen concentration was significantly correlated with A−20C mutation and percent body fat and found that systolic and diastolic blood pressures were significantly correlated with G−6A and T+68C mutations. These results suggest that mutations near the transcription start site may be associated with increased blood pressure.